Skip to content

Risk markers, predictors and mechanisms of psychotherapy in social anxiety disorder

Risk markers, predictors and mechanisms of psychotherapy in social anxiety disorder - VR-SAD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030701
Enrollment
360
Registered
2023-02-15
Start date
2023-09-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F40.1

Interventions

Group 1: Social anxiety disorder intervention group. The intervention group receives standardised, exposition based, cognitive-behavioral psychotherapeutic treatment using virtual reality scenarios (1

Sponsors

Universitätsklinikum Freiburg, Klinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Primary diagnosis of social anxiety disorder (intervention/waitlist control groups only), Caucasian ancestry and German language proficiency.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with social phobia are any comorbid bipolar or schizophrenic/psychotic disorders, autism, substance dependence (except nicotine), acute suicidality, severe neurological and/or somatic disease, illegal drug use, pregnancy, breast-feeding, impaired 3D vision, use of epigenetically active substances, general medical contraindications, or concomitant psychotherapy. The exclusion criteria for the healthy control group are the same as those described above. In addition, the presence of a current or lifetime mental disorder according to DSM-5 (SCID-5-CV; First et al., 2016), excessive alcohol (more than 14 glasses/week), cigarette (more than 20 cigarettes/day), and caffeine consumption (more than 4 cups/day), or use of psychoactive medications will lead to exclusion from the study.

Design outcomes

Primary

MeasureTime frame
Decrease in social phobia symptoms, measured by psychometric diagnostics (e.g. Liebowitz Social Anxiety Scale)

Secondary

MeasureTime frame
Changes in behavioral, physiological, neurobiological, molecular biological and immunological measures.

Countries

Germany

Contacts

Public ContactMiriam Schiele

Universitätsklinikum Freiburg, Klinik für Psychiatrie und Psychotherapie

miriam.schiele@uniklinik-freiburg.de0049 761 270 65540

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026